Mike,
You are correct...I’m somewhat discouraged, and I’m guessing I’m not alone...I do still believe that the novel molecule, and biomass when sufficient supply is produced, will ultimately make up for years of missteps by management...as you have correctly pointed out,and I will not rehash what you have already written, there are definitely some positive things that came from the project update...but as with every PR or project update there is reason for optimism, but this company needs results that yield revenue, or at least funding NOW...its inexplicable at this point in the game for this company to be where they are financially ... When I read about the SIXTEENTH test involving the chickens, and that animal GRAS was nowhere near being achieved, I could feel my blood pressure instantly elevate…The idea of pursuing some “low hanging fruit” that would yield revenue to insure that funding for the current and future verticals is no longer an issue, is one of things that has frustrated me the most over the past several years...my expectations/hope for 2020 were simple...Achieve funding, or at least ONE revenue generating deal that would position ZIVO for 2021, and this was pre-COVID... But it’s early September, two months from the shareholders meeting, and it looks like we will be listening to the same old song and dance from management come November 4th... I’m just tired of waiting and guessing.
